Article (Scientific journals)
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians.
Ramdas, Sithara; Oskoui, Maryam; Servais, Laurent
2024In Drugs, 84 (7), p. 747 - 762
Peer Reviewed verified by ORBi
 

Files


Full Text
Ramdasdrug2024.pdf
Author postprint (849.13 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Risdiplam; nusinersen; Oligonucleotides; Pyrimidines; Zolgensma; Azo Compounds; Biological Products; Recombinant Fusion Proteins; Humans; Oligonucleotides/therapeutic use; Oligonucleotides/pharmacology; Pyrimidines/therapeutic use; Muscular Atrophy, Spinal/drug therapy; Muscular Atrophy, Spinal/therapy; Muscular Atrophy, Spinal; Pharmacology (medical)
Abstract :
[en] Spinal muscular atrophy (SMA) is a rare neurodegenerative neuromuscular disorder with a wide phenotypic spectrum of severity. SMA was previously life limiting for patients with the most severe phenotype and resulted in progressive disability for those with less severe phenotypes. This has changed dramatically in the past few years with the approvals of three disease-modifying treatments. We review the evidence supporting the use of currently approved SMA treatments (nusinersen, onasemnogene abeparvovec, and risdiplam), focusing on mechanisms of action, side effect profiles, published clinical trial data, health economics, and pending questions. Whilst there is robust data from clinical trials of efficacy and side effect profile for individual drugs in select SMA populations, there are no comparative head-to-head clinical trials. This presents a challenge for clinicians who need to make recommendations on the best treatment option for an individual patient and we hope to provide a pragmatic approach for clinicians across each SMA profile based on current evidence.
Disciplines :
Pediatrics
Author, co-author :
Ramdas, Sithara;  Department of Paediatrics, MDUK Oxford Neuromuscular Centre and NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK ; Department of Paediatric Neurology, John Radcliffe Hospital, Oxford, UK
Oskoui, Maryam;  Departments of Pediatrics and Neurology and Neurosurgery, McGill University, Montreal, Canada ; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada
Servais, Laurent  ;  Université de Liège - ULiège > Département des sciences cliniques ; Department of Paediatrics, MDUK Oxford Neuromuscular Centre and NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. Laurent.servais@paediatrics.ox.ac.uk ; Academic Paediatric Department, Level 2 Children Hospital-John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK. Laurent.servais@paediatrics.ox.ac.uk
Language :
English
Title :
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians.
Publication date :
July 2024
Journal title :
Drugs
ISSN :
0012-6667
eISSN :
1179-1950
Publisher :
Adis, New Zealand
Volume :
84
Issue :
7
Pages :
747 - 762
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 December 2024

Statistics


Number of views
92 (0 by ULiège)
Number of downloads
80 (0 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
2
OpenCitations
 
0
OpenAlex citations
 
3

Bibliography


Similar publications



Contact ORBi